IOL Power Calculation Using Dual Schiempflug Analyzer
Precision of Optical Biometry and Intraocular Lens Power Calculation Using Dual Schiempflug Analyzer
1 other identifier
observational
140
1 country
1
Brief Summary
This study evaluates the various ocular parameters which are necessary for ocular biometry and the calculated IOL powers using both dual Schiempflug analyzer and optical low-coherence refelctometry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 9, 2015
CompletedFirst Posted
Study publicly available on registry
February 12, 2015
CompletedFebruary 18, 2015
October 1, 2014
4 months
February 9, 2015
February 15, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Ocular parameters
Parameters measured using two devices were compared at a single point
Single point
Calculated IOL powers
Calculated IOL powers using two devices were compared at a single point
Single point
Eligibility Criteria
140 eyes of patients who scheduled for cataract surgery
You may qualify if:
- axial length between 21.0 and 27.0 mm
- older than 20 years old
You may not qualify if:
- other ophthalmic diseases such as severe dry eye, glaucoma, and age-related macular degeneration
- previous ophthalmic surgery including cataract surgery, and refractive surgery
- very dense media which cannot be measured by the optical biometries
- severe zonulysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chuncheon Sacred Heart Hospital
Chuncheon, 200-798, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kyung Eun Han, MD
Clinical associate professor
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2015
First Posted
February 12, 2015
Study Start
October 1, 2014
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
February 18, 2015
Record last verified: 2014-10